CN115836988B - Cosmetic composition, essence emulsion and preparation method thereof - Google Patents
Cosmetic composition, essence emulsion and preparation method thereof Download PDFInfo
- Publication number
- CN115836988B CN115836988B CN202211114354.XA CN202211114354A CN115836988B CN 115836988 B CN115836988 B CN 115836988B CN 202211114354 A CN202211114354 A CN 202211114354A CN 115836988 B CN115836988 B CN 115836988B
- Authority
- CN
- China
- Prior art keywords
- phase
- percent
- active component
- raw materials
- following raw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 239000000839 emulsion Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 238000004945 emulsification Methods 0.000 title description 2
- 239000002994 raw material Substances 0.000 claims abstract description 117
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 87
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 101000623895 Bos taurus Mucin-15 Proteins 0.000 claims abstract description 25
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 25
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 23
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 22
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 18
- -1 methylglucal sesquistearate Chemical compound 0.000 claims abstract description 14
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims abstract description 12
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 11
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 11
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 11
- 229960001631 carbomer Drugs 0.000 claims abstract description 11
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 11
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 11
- 229960002216 methylparaben Drugs 0.000 claims abstract description 11
- 239000002480 mineral oil Substances 0.000 claims abstract description 11
- 235000010446 mineral oil Nutrition 0.000 claims abstract description 11
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940100460 peg-100 stearate Drugs 0.000 claims abstract description 11
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 11
- 229940057874 phenyl trimethicone Drugs 0.000 claims abstract description 11
- 229960003415 propylparaben Drugs 0.000 claims abstract description 11
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 11
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 11
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims abstract description 11
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims abstract description 11
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000230 xanthan gum Substances 0.000 claims abstract description 11
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 11
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 11
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 11
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 9
- 229940046009 vitamin E Drugs 0.000 claims abstract description 9
- 239000011709 vitamin E Substances 0.000 claims abstract description 9
- 229940082500 cetostearyl alcohol Drugs 0.000 claims abstract 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract 6
- 239000000126 substance Substances 0.000 claims description 31
- 230000001804 emulsifying effect Effects 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 18
- 238000010438 heat treatment Methods 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 13
- 239000003921 oil Substances 0.000 claims description 13
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 12
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 12
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 12
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 12
- XYTHHAXRVHHXKO-JIUYZRCGSA-N 18-[(2r,3s,4r,5r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxyoctadecanoic acid;ethanol Chemical compound CCO.COC1O[C@H](CO)[C@@H](OCCCCCCCCCCCCCCCCCC(O)=O)[C@H](O)[C@H]1O XYTHHAXRVHHXKO-JIUYZRCGSA-N 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 9
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 6
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 6
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 6
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 6
- 244000025254 Cannabis sativa Species 0.000 claims description 6
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 6
- 241000186660 Lactobacillus Species 0.000 claims description 6
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- 229960004551 cotton seed extract Drugs 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 6
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 claims description 6
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 6
- 229940039696 lactobacillus Drugs 0.000 claims description 6
- 239000008267 milk Substances 0.000 claims description 6
- 210000004080 milk Anatomy 0.000 claims description 6
- 235000013336 milk Nutrition 0.000 claims description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 6
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229940068968 polysorbate 80 Drugs 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 238000005086 pumping Methods 0.000 claims description 6
- 229940109850 royal jelly Drugs 0.000 claims description 6
- 229940047670 sodium acrylate Drugs 0.000 claims description 6
- 229950004959 sorbitan oleate Drugs 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims 2
- 229930003231 vitamin Natural products 0.000 claims 2
- 229940088594 vitamin Drugs 0.000 claims 2
- 235000013343 vitamin Nutrition 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims 2
- 244000020551 Helianthus annuus Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 abstract description 7
- 230000004054 inflammatory process Effects 0.000 abstract description 7
- 230000009759 skin aging Effects 0.000 abstract description 6
- 229960005150 glycerol Drugs 0.000 abstract 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 abstract 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 230000037394 skin elasticity Effects 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 241000208818 Helianthus Species 0.000 description 5
- 108090001007 Interleukin-8 Proteins 0.000 description 5
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 5
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000013064 chemical raw material Substances 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 229940075529 glyceryl stearate Drugs 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 235000021283 resveratrol Nutrition 0.000 description 5
- 229940016667 resveratrol Drugs 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 2
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000003399 chemotactic effect Effects 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 229940033329 phytosphingosine Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- KBHSAMYHDBBRKS-QTJGBDASSA-N 2-hydroxy-n-[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]benzamide Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)C1=CC=CC=C1O KBHSAMYHDBBRKS-QTJGBDASSA-N 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- JQEZTZLPYYCTSU-UHFFFAOYSA-N COC1=C(C(=C(C(=C1O)C1=C(C=CC=C1)C)O)CCC)OC Chemical compound COC1=C(C(=C(C(=C1O)C1=C(C=CC=C1)C)O)CCC)OC JQEZTZLPYYCTSU-UHFFFAOYSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 101710112752 Cytotoxin Proteins 0.000 description 1
- 241000723289 Dianella <angiosperm> Species 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 210000000447 Th1 cell Anatomy 0.000 description 1
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940077859 salicyloyl phytosphingosine Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 230000005951 type IV hypersensitivity Effects 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Abstract
The invention discloses a cosmetic composition, essence emulsion and a preparation method thereof, and belongs to the technical field of cosmetics. The phase-A-phase-B-phase-C-phase-D-circuit comprises a phase A phase, a phase B phase, a phase C phase and a phase D phase; wherein the phase A comprises the following raw materials: mineral oil, glycerol stearate, cetostearyl alcohol, PEG-20 methylglucal sesquistearate, dioctyl butylene carbonate/vitamin E, glycerol stearate/PEG-100 stearate, phenyl trimethicone, methylparaben, propylparaben, caprylic/capric triglyceride; wherein the phase B comprises the following raw materials: glycerol, xanthan gum, carbomer, active component I, sodium hyaluronate, butanediol and the balance of water; wherein the phase C comprises the following raw materials: triethanolamine, an active component II, wherein the phase D comprises the following raw materials: active component III, active component IV, phenoxyethanol, essence and active component V. Based on the combination of a plurality of active components, the preparation can obviously inhibit the inflammatory reaction on one hand and reduce the skin aging phenomenon on the other hand.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a cosmetic composition, essence emulsion and a preparation method thereof.
Background
Skin aging is characterized in that oxygen free radicals attack collagen and elastic fibers in skin to cause collagen denaturation and elastic fiber fracture; on the other hand, with age, the proliferation rate of collagen and elastin in skin is slowed down, and damaged parts cannot be compensated in time; meanwhile, along with aging, the skin can generate color spots, and then the skin can develop into senile plaques; the skin gradually loses elasticity and becomes loose, wrinkles and spots are formed. Skin anti-aging cosmetics are increasingly popular with the aged society. Skin aging resistance is a comprehensive process, on one hand, the generation of oxygen free radicals in skin is reduced or the oxygen free radicals are timely removed; on the other hand, it is required to remove wrinkles by accelerating the removal of old skin horns and generating new collagen, and it is also required to remove or suppress the occurrence of color spots. Resveratrol is a natural antioxidant existing in plants, and is mainly extracted from plant polygonum cuspidatum at present mainly by scavenging or inhibiting oxygen free radicals and inhibiting lipid peroxidation; dimethoxy tolyl-4-propyl resorcinol is a phenolic compound, can inhibit the generation of oxygen free radicals, is mainly extracted from plant dianella, and has remarkable freckle-removing and whitening effects at present; the salicyloyl phytosphingosine can induce collagen in dermal papilla layer to smooth skin, and can help to remove old skin cutin and relieve wrinkles generated in skin aging process. Aiming at the skin anti-aging mechanism, the resveratrol, dimethoxy tolyl-4-propyl resorcinol and salicyl phytosphingosine are compounded and all-round anti-aging is realized. However, resveratrol, dimethoxytolyl-4-propylresorcinol and salicyl phytosphingosine are all dissolved in ethanol and are insoluble in water and oil, so that the application is difficult; the resveratrol has strong dimethoxy tolyl-4-propyl resorcinol activity and very poor stability, for example, 40% ethanol solution of resveratrol can be stable for only a few days under the condition of avoiding light, and can not keep activity in cosmetics for a long time; therefore, although the effect is remarkable, it is very difficult to use it in cosmetics.
Disclosure of Invention
1. Problems to be solved
Aiming at the problems in the prior art, the invention provides the cosmetic composition, the essence emulsion and the preparation method thereof, which have simple components and are easy to prepare, and on the basis of the cooperation of a plurality of active components, the cosmetic composition can obviously inhibit the inflammatory reaction on one hand, can reduce the skin aging phenomenon on the other hand, can improve the elastic parameters of the skin, can permeate into the skin by means of the essence emulsion, and has excellent performance due to the synergistic interaction among various parameter conditions.
2. Technical proposal
In order to solve the problems, the invention adopts the following technical scheme.
A cosmetic composition comprises phase A, phase B, phase C, and phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.1 to 0.3 percent of triethanolamine,
0.3% -1% Of active component II;
wherein the phase D comprises the following raw materials:
In the cosmetic composition described above,
Comprises a phase A, a phase B, a phase C and a phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.1 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
In the cosmetic composition described above,
Comprises a phase A, a phase B, a phase C and a phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.3 percent of triethanolamine,
0.3% Of active component II;
wherein the phase D comprises the following raw materials:
In the cosmetic composition described above,
Comprises a phase A, a phase B, a phase C and a phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.1 percent of triethanolamine,
0.3% Of active component II;
wherein the phase D comprises the following raw materials:
In the cosmetic composition described above,
Comprises a phase A, a phase B, a phase C and a phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.3 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
In the cosmetic composition described above,
The mineral oil is purchased from Guangzhou Dishiman trade Limited company;
the glyceryl stearate is purchased from Guangzhou Dishiman trade company;
the cetylstearyl alcohol was purchased from australian biotechnology limited, guangzhou;
The PEG-20 methyl glucose sesquistearate is purchased from Rongdao chemical industry Co., guangzhou;
the butylene glycol dioctyl carbonate/vitamin E is purchased from Xin An chemical industry trade Limited company in the Buddha city, and the mass ratio is 1:1, a step of;
the glycerol stearate/PEG-100 stearate is purchased from chemical industry Co-Ltd on the Kju day of Guangzhou, and the mass ratio is 1:1, a step of;
the phenyl trimethicone was purchased from Cisco Biotechnology Inc. of Guangzhou;
The methylparaben is purchased from Guangzhou Heng taug trade limited company;
the propyl hydroxybenzoate is purchased from Guangzhou Heng Taobao trade Limited company;
the caprylic/capric triglyceride is purchased from chemical industry limited company for Kju day, guangzhou, and the mass ratio is 1:1, a step of;
the glycerol purchase is from Guangzhou Dishiman trade Limited company;
The xanthan gum is purchased from Guangzhou city Boyi chemical raw material limited company;
the carbomer purchase was from guangzhou megabalance trade development limited,
The active component is purchased from Hunan Jia extract biotechnology limited company, and comprises the components of water, glycerol, butanediol, epigallocatechin gallate, hydrolyzed coffee yellow sunflower extract, hydroxylated lecithin, 1, 2-hexanediol and p-hydroxyacetophenone;
the sodium hyaluronate is purchased from Guangzhou Yujin trade company;
The butanediol is purchased from Guangzhou Hui chemical technology limited company;
In the cosmetic composition described above,
The triethanolamine is purchased from Guangzhou Heng Taobao trade Limited company;
The active component II is purchased from Bai Hao Bo Co., guangzhou, and comprises sodium acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, polysorbate-80, sorbitan oleate and water.
In the cosmetic composition described above,
The active component is purchased from the chemical industry limited company of the megahonum in Guangzhou, and comprises the components of water, lactobacillus/soybean milk fermentation product filtrate, butanediol and 1, 2-pentanediol;
The active component is purchased from Guangzhou Siyi biotechnology limited company and comprises the following components of royal jelly extract, glycerol, water, 1, 2-hexanediol and ethylhexyl glycerol;
the phenoxyethanol is purchased from Guangzhou Heng Taobao trade Limited company;
The essence is purchased from Guangzhou Fenhao essence limited company;
The active component five is purchased from Guangzhou North Biotechnology Co., ltd, and comprises glycerol, grass cotton seed extract and citric acid.
An essential emulsion comprising the cosmetic composition.
The preparation method of the essence emulsion comprises the following steps:
(1) Adding the phase A raw material into an oil phase pot, stirring and heating to 80-82 ℃ until the phase A raw material is completely dissolved and has no particles for standby;
(2) Adding the B phase raw material into an emulsifying pot, uniformly stirring, heating to 82-85 ℃, homogenizing for 5-10 min until the B phase raw material is completely dissolved and has no particles for later use;
(3) Pumping the materials in the oil phase pot into an emulsifying pot, emulsifying and homogenizing for 3min-5min, and preserving heat for 15min at 82-85 ℃;
(4) Heating the C-phase raw material to 80 ℃, sequentially adding the C-phase raw material into an emulsifying pot, uniformly stirring, homogenizing for 3-5 min, and keeping vacuum cooling;
(5) Cooling to 45deg.C, sequentially adding the D phase materials into emulsifying pot, stirring, filtering, and discharging.
3. Advantageous effects
Compared with the prior art, the invention has the beneficial effects that:
Based on the matched use of a plurality of active components, on one hand, the inflammatory reaction can be obviously inhibited, on the other hand, the skin aging phenomenon can be reduced, the elastic parameters of the skin can be improved, the skin can be permeated by the essence emulsion, and the conditions of the parameters are synergistically enhanced, so that the excellent performance is shown.
Detailed Description
The invention is further described below in connection with specific embodiments.
Example 1
Cosmetic compositions comprising phase A, phase B, phase C, phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.1 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
In the cosmetic composition described above,
The mineral oil is purchased from Guangzhou Dishiman trade Limited company;
the glyceryl stearate is purchased from Guangzhou Dishiman trade company;
the cetylstearyl alcohol was purchased from australian biotechnology limited, guangzhou;
The PEG-20 methyl glucose sesquistearate is purchased from Rongdao chemical industry Co., guangzhou;
the butylene glycol dioctyl carbonate/vitamin E is purchased from Xin An chemical industry trade Limited company in the Buddha city, and the mass ratio is 1:1, a step of;
the glycerol stearate/PEG-100 stearate is purchased from chemical industry Co-Ltd on the Kju day of Guangzhou, and the mass ratio is 1:1, a step of;
the phenyl trimethicone was purchased from Cisco Biotechnology Inc. of Guangzhou;
The methylparaben is purchased from Guangzhou Heng taug trade limited company;
the propyl hydroxybenzoate is purchased from Guangzhou Heng Taobao trade Limited company;
the caprylic/capric triglyceride is purchased from chemical industry limited company for Kju day, guangzhou, and the mass ratio is 1:1, a step of;
the glycerol purchase is from Guangzhou Dishiman trade Limited company;
The xanthan gum is purchased from Guangzhou city Boyi chemical raw material limited company;
the carbomer purchase was from guangzhou megabalance trade development limited,
The active component is purchased from Hunan Jia extract biotechnology limited company, and comprises the components of water, glycerol, butanediol, epigallocatechin gallate, hydrolyzed coffee yellow sunflower extract, hydroxylated lecithin, 1, 2-hexanediol and p-hydroxyacetophenone;
the sodium hyaluronate is purchased from Guangzhou Yujin trade company;
The butanediol is purchased from Guangzhou Hui chemical technology limited company;
In the cosmetic composition described above,
The triethanolamine is purchased from Guangzhou Heng Taobao trade Limited company;
The active component II is purchased from Bai Hao Bo Co., guangzhou, and comprises sodium acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, polysorbate-80, sorbitan oleate and water.
In the cosmetic composition described above,
The active component is purchased from the chemical industry limited company of the megahonum in Guangzhou, and comprises the components of water, lactobacillus/soybean milk fermentation product filtrate, butanediol and 1, 2-pentanediol;
The active component is purchased from Guangzhou Siyi biotechnology limited company and comprises the following components of royal jelly extract, glycerol, water, 1, 2-hexanediol and ethylhexyl glycerol;
the phenoxyethanol is purchased from Guangzhou Heng Taobao trade Limited company;
The essence is purchased from Guangzhou Fenhao essence limited company;
The active component five is purchased from Guangzhou North Biotechnology Co., ltd, and comprises glycerol, grass cotton seed extract and citric acid.
The essence emulsion comprises the cosmetic composition.
The preparation method of the essence emulsion comprises the following steps:
(1) Adding the phase A raw material into an oil phase pot, stirring and heating to 80 ℃ until the phase A raw material is completely dissolved and has no particles for standby;
(2) Adding the B phase raw material into an emulsifying pot, stirring uniformly, heating to 82 ℃, homogenizing for 5min until the B phase raw material is completely dissolved and has no particles for standby;
(3) Pumping the materials in the oil phase pot into an emulsifying pot, emulsifying and homogenizing for 3min, and preserving the temperature for 15min at 82 ℃;
(4) Heating the C-phase raw material to 80 ℃, sequentially adding the C-phase raw material into an emulsifying pot, uniformly stirring, homogenizing for 3min, and maintaining vacuum cooling;
(5) Cooling to 45deg.C, sequentially adding the D phase materials into emulsifying pot, stirring, filtering, and discharging.
Example 2
Cosmetic compositions comprising phase A, phase B, phase C, phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.3 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
In the cosmetic composition described above,
The mineral oil is purchased from Guangzhou Dishiman trade Limited company;
the glyceryl stearate is purchased from Guangzhou Dishiman trade company;
the cetylstearyl alcohol was purchased from australian biotechnology limited, guangzhou;
The PEG-20 methyl glucose sesquistearate is purchased from Rongdao chemical industry Co., guangzhou;
the butylene glycol dioctyl carbonate/vitamin E is purchased from Xin An chemical industry trade Limited company in the Buddha city, and the mass ratio is 1:1, a step of;
the glycerol stearate/PEG-100 stearate is purchased from chemical industry Co-Ltd on the Kju day of Guangzhou, and the mass ratio is 1:1, a step of;
the phenyl trimethicone was purchased from Cisco Biotechnology Inc. of Guangzhou;
The methylparaben is purchased from Guangzhou Heng taug trade limited company;
the propyl hydroxybenzoate is purchased from Guangzhou Heng Taobao trade Limited company;
the caprylic/capric triglyceride is purchased from chemical industry limited company for Kju day, guangzhou, and the mass ratio is 1:1, a step of;
the glycerol purchase is from Guangzhou Dishiman trade Limited company;
The xanthan gum is purchased from Guangzhou city Boyi chemical raw material limited company;
the carbomer purchase was from guangzhou megabalance trade development limited,
The active component is purchased from Hunan Jia extract biotechnology limited company, and comprises the components of water, glycerol, butanediol, epigallocatechin gallate, hydrolyzed coffee yellow sunflower extract, hydroxylated lecithin, 1, 2-hexanediol and p-hydroxyacetophenone;
the sodium hyaluronate is purchased from Guangzhou Yujin trade company;
The butanediol is purchased from Guangzhou Hui chemical technology limited company;
In the cosmetic composition described above,
The triethanolamine is purchased from Guangzhou Heng Taobao trade Limited company;
The active component II is purchased from Bai Hao Bo Co., guangzhou, and comprises sodium acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, polysorbate-80, sorbitan oleate and water.
In the cosmetic composition described above,
The active component is purchased from the chemical industry limited company of the megahonum in Guangzhou, and comprises the components of water, lactobacillus/soybean milk fermentation product filtrate, butanediol and 1, 2-pentanediol;
The active component is purchased from Guangzhou Siyi biotechnology limited company and comprises the following components of royal jelly extract, glycerol, water, 1, 2-hexanediol and ethylhexyl glycerol;
the phenoxyethanol is purchased from Guangzhou Heng Taobao trade Limited company;
The essence is purchased from Guangzhou Fenhao essence limited company;
The active component five is purchased from Guangzhou North Biotechnology Co., ltd, and comprises glycerol, grass cotton seed extract and citric acid.
The essence emulsion comprises the cosmetic composition.
The preparation method of the essence emulsion comprises the following steps:
(1) Adding the phase A raw material into an oil phase pot, stirring and heating to 82 ℃ until the phase A raw material is completely dissolved and has no particles for standby;
(2) Adding the B phase raw material into an emulsifying pot, stirring uniformly, heating to 85 ℃, homogenizing for 10min until the B phase raw material is completely dissolved and has no particles for standby;
(3) Pumping the materials in the oil phase pot into an emulsifying pot for emulsifying and homogenizing for 5min, and preserving the temperature at 85 ℃ for 15min;
(4) Heating the C-phase raw material to 80 ℃, sequentially adding the C-phase raw material into an emulsifying pot, uniformly stirring, homogenizing for 5min, and maintaining vacuum cooling;
(5) Cooling to 45deg.C, sequentially adding the D phase materials into emulsifying pot, stirring, filtering, and discharging.
Example 3
Cosmetic compositions comprising phase A, phase B, phase C, phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.1 percent of triethanolamine,
0.3% Of active component II;
wherein the phase D comprises the following raw materials:
In the cosmetic composition described above,
The mineral oil is purchased from Guangzhou Dishiman trade Limited company;
the glyceryl stearate is purchased from Guangzhou Dishiman trade company;
the cetylstearyl alcohol was purchased from australian biotechnology limited, guangzhou;
The PEG-20 methyl glucose sesquistearate is purchased from Rongdao chemical industry Co., guangzhou;
the butylene glycol dioctyl carbonate/vitamin E is purchased from Xin An chemical industry trade Limited company in the Buddha city, and the mass ratio is 1:1, a step of;
the glycerol stearate/PEG-100 stearate is purchased from chemical industry Co-Ltd on the Kju day of Guangzhou, and the mass ratio is 1:1, a step of;
the phenyl trimethicone was purchased from Cisco Biotechnology Inc. of Guangzhou;
The methylparaben is purchased from Guangzhou Heng taug trade limited company;
the propyl hydroxybenzoate is purchased from Guangzhou Heng Taobao trade Limited company;
the caprylic/capric triglyceride is purchased from chemical industry limited company for Kju day, guangzhou, and the mass ratio is 1:1, a step of;
the glycerol purchase is from Guangzhou Dishiman trade Limited company;
The xanthan gum is purchased from Guangzhou city Boyi chemical raw material limited company;
the carbomer purchase was from guangzhou megabalance trade development limited,
The active component is purchased from Hunan Jia extract biotechnology limited company, and comprises the components of water, glycerol, butanediol, epigallocatechin gallate, hydrolyzed coffee yellow sunflower extract, hydroxylated lecithin, 1, 2-hexanediol and p-hydroxyacetophenone;
the sodium hyaluronate is purchased from Guangzhou Yujin trade company;
The butanediol is purchased from Guangzhou Hui chemical technology limited company;
In the cosmetic composition described above,
The triethanolamine is purchased from Guangzhou Heng Taobao trade Limited company;
The active component II is purchased from Bai Hao Bo Co., guangzhou, and comprises sodium acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, polysorbate-80, sorbitan oleate and water.
In the cosmetic composition described above,
The active component is purchased from the chemical industry limited company of the megahonum in Guangzhou, and comprises the components of water, lactobacillus/soybean milk fermentation product filtrate, butanediol and 1, 2-pentanediol;
The active component is purchased from Guangzhou Siyi biotechnology limited company and comprises the following components of royal jelly extract, glycerol, water, 1, 2-hexanediol and ethylhexyl glycerol;
the phenoxyethanol is purchased from Guangzhou Heng Taobao trade Limited company;
The essence is purchased from Guangzhou Fenhao essence limited company;
The active component five is purchased from Guangzhou North Biotechnology Co., ltd, and comprises glycerol, grass cotton seed extract and citric acid.
The essence emulsion comprises the cosmetic composition.
The preparation method of the essence emulsion comprises the following steps:
(1) Adding the phase A raw material into an oil phase pot, stirring and heating to 80 ℃ until the phase A raw material is completely dissolved and has no particles for standby;
(2) Adding the B phase raw material into an emulsifying pot, stirring uniformly, heating to 85 ℃, homogenizing for 5min until the B phase raw material is completely dissolved and has no particles for standby;
(3) Pumping the materials in the oil phase pot into an emulsifying pot for emulsifying and homogenizing for 5min, and preserving the temperature for 15min at 82 ℃;
(4) Heating the C-phase raw material to 80 ℃, sequentially adding the C-phase raw material into an emulsifying pot, uniformly stirring, homogenizing for 5min, and maintaining vacuum cooling;
(5) Cooling to 45deg.C, sequentially adding the D phase materials into emulsifying pot, stirring, filtering, and discharging.
Example 4
Cosmetic compositions comprising phase A, phase B, phase C, phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.3 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
/>
In the cosmetic composition described above,
The mineral oil is purchased from Guangzhou Dishiman trade Limited company;
the glyceryl stearate is purchased from Guangzhou Dishiman trade company;
the cetylstearyl alcohol was purchased from australian biotechnology limited, guangzhou;
The PEG-20 methyl glucose sesquistearate is purchased from Rongdao chemical industry Co., guangzhou;
the butylene glycol dioctyl carbonate/vitamin E is purchased from Xin An chemical industry trade Limited company in the Buddha city, and the mass ratio is 1:1, a step of;
the glycerol stearate/PEG-100 stearate is purchased from chemical industry Co-Ltd on the Kju day of Guangzhou, and the mass ratio is 1:1, a step of;
the phenyl trimethicone was purchased from Cisco Biotechnology Inc. of Guangzhou;
The methylparaben is purchased from Guangzhou Heng taug trade limited company;
the propyl hydroxybenzoate is purchased from Guangzhou Heng Taobao trade Limited company;
the caprylic/capric triglyceride is purchased from chemical industry limited company for Kju day, guangzhou, and the mass ratio is 1:1, a step of;
the glycerol purchase is from Guangzhou Dishiman trade Limited company;
The xanthan gum is purchased from Guangzhou city Boyi chemical raw material limited company;
the carbomer purchase was from guangzhou megabalance trade development limited,
The active component is purchased from Hunan Jia extract biotechnology limited company, and comprises the components of water, glycerol, butanediol, epigallocatechin gallate, hydrolyzed coffee yellow sunflower extract, hydroxylated lecithin, 1, 2-hexanediol and p-hydroxyacetophenone;
the sodium hyaluronate is purchased from Guangzhou Yujin trade company;
The butanediol is purchased from Guangzhou Hui chemical technology limited company;
In the cosmetic composition described above,
The triethanolamine is purchased from Guangzhou Heng Taobao trade Limited company;
The active component II is purchased from Bai Hao Bo Co., guangzhou, and comprises sodium acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, polysorbate-80, sorbitan oleate and water.
In the cosmetic composition described above,
The active component is purchased from the chemical industry limited company of the megahonum in Guangzhou, and comprises the components of water, lactobacillus/soybean milk fermentation product filtrate, butanediol and 1, 2-pentanediol;
The active component is purchased from Guangzhou Siyi biotechnology limited company and comprises the following components of royal jelly extract, glycerol, water, 1, 2-hexanediol and ethylhexyl glycerol;
the phenoxyethanol is purchased from Guangzhou Heng Taobao trade Limited company;
The essence is purchased from Guangzhou Fenhao essence limited company;
The active component five is purchased from Guangzhou North Biotechnology Co., ltd, and comprises glycerol, grass cotton seed extract and citric acid.
The essence emulsion comprises the cosmetic composition.
The preparation method of the essence emulsion comprises the following steps:
(1) Adding the phase A raw material into an oil phase pot, stirring and heating to 82 ℃ until the phase A raw material is completely dissolved and has no particles for standby;
(2) Adding the B phase raw material into an emulsifying pot, stirring uniformly, heating to 82 ℃, homogenizing for 10min until the B phase raw material is completely dissolved and has no particles for standby;
(3) Pumping the materials in the oil phase pot into an emulsifying pot, emulsifying and homogenizing for 3min, and preserving the temperature at 85 ℃ for 15min;
(4) Heating the C-phase raw material to 80 ℃, sequentially adding the C-phase raw material into an emulsifying pot, uniformly stirring, homogenizing for 3min, and maintaining vacuum cooling;
(5) Cooling to 45deg.C, sequentially adding the D phase materials into emulsifying pot, stirring, filtering, and discharging.
Comparative example
Comparison scheme one: the cosmetic composition and the essence emulsion of this example are basically the same as in example 1, except that the following matters are adopted:
cosmetic compositions comprising phase A, phase B, phase C, phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.3 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
And a comparison scheme II:
cosmetic compositions comprising phase A, phase B, phase C, phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
Triethanolamine 0.3%;
wherein the phase D comprises the following raw materials:
And a comparison scheme III:
cosmetic compositions comprising phase A, phase B, phase C, phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.3 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
And a comparison scheme IV:
cosmetic compositions comprising phase A, phase B, phase C, phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.3 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
Comparison scheme five:
cosmetic compositions comprising phase A, phase B, phase C, phase D;
The phase A comprises the following raw materials in percentage by mass:
Wherein the phase B comprises the following raw materials:
Wherein the phase C comprises the following raw materials:
0.3 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
test case
Samples prepared by the technical schemes of example 1, example 2, example 3 and example 4, and samples prepared by the technical schemes of the comparative schemes were selected and tested as follows:
Anti-inflammatory performance test:
IL-8 is a cytokine secreted by Th1 cells, mainly mediates the generation of immune response auxiliary antibodies related to cytotoxin and local inflammation, participates in the generation of cellular immunity and delayed type hypersensitive inflammation, has the main biological effects of chemotactic and activation of neutrophils, promotes the lysosomal enzyme activity and phagocytosis of the neutrophils, has a certain chemotactic effect on basophils and T cells, has morphological change after the neutrophils are contacted with the IL-8, directionally moves to a reaction part and releases a series of active products, and can lead to local inflammatory reactions of organisms, thereby achieving the purposes of sterilizing and damaging the cells.
Experimental materials: ku812 cells were supplied by the center of chinese academy of cells; RPMI1640, IMDM medium, penicillin, streptomycin were all purchased from Gibco; fetal bovine serum was purchased from HyClone company; DMSO, PMA, and a12387 were purchased from Sigma; IL-8 kits were purchased from R & D systems; mu Q mu ant microplate reader was purchased from BIO-TEK company.
Sample preparation of an experimental method: the resulting cream of examples 1-4 and comparative protocol was formulated with DMSO or double distilled water and diluted to a concentration of 25mg/mL in a medium containing 10% fetal bovine serum.
Ku812 cell density was adjusted to 2.2x10 6/mL cell suspension in IMDM medium containing 10% fetal bovine serum and seeded in 96-well plates at 200 μl per well. Setting a cell blank control group, an example group and a comparison example group, wherein each group is provided with 3 parallel holes, culturing and standing for 10min in a culture box with 5% CO 2 at 37 ℃, adding samples with the final concentration of 50 mug/mL into the example group and the comparison scheme group, pre-incubating in the culture box for 15min, adding a stimulator PMA and A12387 into each group of cells except the cell blank group, so that the final concentration is 5nm and 1 mu m respectively, and adding the same volume of DMSO culture medium with the same concentration into the cell blank group. After 2h, the cells were centrifuged, and the cell supernatant was collected and the IL-8 content of the supernatant was measured. In addition, a model group was set, and the treatment was performed in the same manner as in the example group or the comparative example group, but without adding a sample.
TABLE 1IL-8 assay results
In combination with Table 1, the products prepared in examples 1-4 of the present application have a significant effect of inhibiting skin inflammation compared to the model group and the comparative regimen group. Specifically, the raw materials of the first to fifth active components can solve the problems of skin inflammation such as redness, itching and the like caused by ultraviolet injury, free radical oxidation, environmental pollution, excessive sebum secretion, bacterial infection and the like by inhibiting IL-8 to play a role in inhibiting IV type hypersensitivity reaction (delayed type hypersensitivity reaction), and supposedly play a role in inhibiting the high expression of inflammatory factors, thereby inhibiting the increase of capillary permeability and the occurrence of inflammation and allergy phenomena caused by histamine release.
Anti-aging test: the skin elasticity test was performed on test areas inside the forearms of both hands of a subject using the skin elasticity tester Cutometer Dual MPA580,580 of the germany CK company to reflect the anti-aging effect of the present invention, and the average value of the skin elasticity values of each test area was measured 3 times, the closer to 1 the better. Finally, the average values of the skin elasticity values of the subjects of examples 1 to 4 and the comparative example protocol were counted 30.
TABLE 2 skin elasticity values
/>
As can be seen from Table 2, the products prepared in examples 1-4 according to the present invention have skin elasticity values ranging from 0.87 to 0.92, with a better significant difference in elasticity parameters compared to the comparative examples. On the basis of the prior art, a plurality of active ingredients are introduced, and nutrition ingredients are reserved as much as possible in the preparation method, so that the essence emulsion permeates into the skin, and the excellent performance is shown by the synergy among all parameter conditions.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are, therefore, to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Furthermore, it should be understood that although the present disclosure describes embodiments, not every embodiment is provided with a separate embodiment, and that this description is provided for clarity only, and that the disclosure is not limited to the embodiments described in detail below, and that the embodiments described in the examples may be combined as appropriate to form other embodiments that will be apparent to those skilled in the art.
Claims (7)
1. A cosmetic composition characterized by: comprises a phase A, a phase B, a phase C and a phase D;
The phase A comprises the following raw materials in percentage by mass:
1% -4% of mineral oil,
0.5 To 1.5 percent of glycerol stearate,
0.5 To 2 percent of cetostearyl alcohol,
PEG-20 methyl glucose sesquistearate 0.5-1.5%,
0.5 To 3 percent of dioctyl butylene carbonate/vitamin E,
0.5% -1.5% Of glycerol stearate/PEG-100 stearate,
Phenyl trimethicone 0.5% -1.5%,
0.1 To 0.2 percent of methylparaben,
0.1 To 0.2 percent of propyl hydroxybenzoate,
1% -3% Of caprylic/capric triglyceride;
Wherein the phase B comprises the following raw materials:
3% -5% of glycerol,
0.1 To 0.3 percent of xanthan gum,
0.1 To 0.3 percent of carbomer,
0.5% -2% Of active component one,
0.01% -0.1% Of sodium hyaluronate,
3 To 5 percent of butanediol,
The balance being water;
Wherein the phase C comprises the following raw materials:
0.1 to 0.3 percent of triethanolamine,
0.3% -1% Of active component II;
wherein the phase D comprises the following raw materials:
The active component III is 0.5% -2%,
The active component IV is 0.5% -2%,
0.4 To 0.6 percent of phenoxyethanol,
0.01% -0.05% Of essence,
Active component five 0.5% -2%;
The active component is purchased from Hunan Jia extract biotechnology limited company, and comprises the components of water, glycerol, butanediol, epigallocatechin gallate, hydrolyzed coffee yellow sunflower extract, hydroxylated lecithin, 1, 2-hexanediol and p-hydroxyacetophenone;
The active component II is purchased from Bai Hao Bo Co., guangzhou, and comprises sodium acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, polysorbate-80, sorbitan oleate and water;
The active component is purchased from the chemical industry limited company of the megahonum in Guangzhou, and comprises the components of water, lactobacillus/soybean milk fermentation product filtrate, butanediol and 1, 2-pentanediol;
The active component is purchased from Guangzhou Siyi biotechnology limited company and comprises the following components of royal jelly extract, glycerol, water, 1, 2-hexanediol and ethylhexyl glycerol;
The active component five is purchased from Guangzhou North Biotechnology Co., ltd, and comprises glycerol, grass cotton seed extract and citric acid.
2. The cosmetic composition according to claim 1, characterized in that: comprises a phase A, a phase B, a phase C and a phase D;
The phase A comprises the following raw materials in percentage by mass:
1 percent of mineral oil,
Glycerol stearate 1.5%,
Cetostearyl alcohol 0.5%,
1.5% Of PEG-20 methyl glucose sesquistearate,
0.5 Percent of dioctyl butylene carbonate/vitamin E,
Glycerol stearate/PEG-100 stearate 1.5%,
Phenyl trimethicone 0.5%,
0.2 Percent of methylparaben,
0.1 Percent of propyl hydroxybenzoate,
Caprylic/capric triglyceride 3%;
Wherein the phase B comprises the following raw materials:
3% of glycerol,
0.3 Percent of xanthan gum,
Carbomer 0.1%,
2% Of active component,
0.01 Percent of sodium hyaluronate,
5 Percent of butanediol,
The balance being water;
Wherein the phase C comprises the following raw materials:
0.1 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
Three active components of 0.5 percent,
The active component is four percent 2 percent,
0.4 Percent of phenoxyethanol,
0.05 Percent of essence,
Five 2% of active component.
3. The cosmetic composition according to claim 1, characterized in that: comprises a phase A, a phase B, a phase C and a phase D;
The phase A comprises the following raw materials in percentage by mass:
4% of mineral oil,
0.5 Percent of glycerol stearate,
Cetostearyl alcohol 2%,
PEG-20 methyl glucose sesquistearate 0.5%,
Dioctyl butylene carbonate/vitamin E3%,
Glycerol stearate/PEG-100 stearate 0.5%,
Phenyl trimethicone 1.5%,
0.1 Percent of methylparaben,
0.2 Percent of propyl hydroxybenzoate,
Caprylic/capric triglyceride 1%;
Wherein the phase B comprises the following raw materials:
5% of glycerol,
0.1 Percent of xanthan gum,
0.3% Of carbomer,
0.5 Percent of active component I,
0.1 Percent of sodium hyaluronate,
3% Of butanediol,
The balance being water;
Wherein the phase C comprises the following raw materials:
0.3 percent of triethanolamine,
0.3% Of active component II;
wherein the phase D comprises the following raw materials:
three active components of 2 percent,
Four active components of 0.5 percent,
0.6 Percent of phenoxyethanol,
0.01 Percent of essence,
Five 0.5% of active component.
4. The cosmetic composition according to claim 1, characterized in that: comprises a phase A, a phase B, a phase C and a phase D;
The phase A comprises the following raw materials in percentage by mass:
1 percent of mineral oil,
0.5 Percent of glycerol stearate,
Cetostearyl alcohol 0.5%,
PEG-20 methyl glucose sesquistearate 0.5%,
0.5 Percent of dioctyl butylene carbonate/vitamin E,
Glycerol stearate/PEG-100 stearate 0.5%,
Phenyl trimethicone 0.5%,
0.1 Percent of methylparaben,
0.1 Percent of propyl hydroxybenzoate,
Caprylic/capric triglyceride 1%;
Wherein the phase B comprises the following raw materials:
3% of glycerol,
0.1 Percent of xanthan gum,
Carbomer 0.1%,
0.5 Percent of active component I,
0.01 Percent of sodium hyaluronate,
3% Of butanediol,
The balance being water;
Wherein the phase C comprises the following raw materials:
0.1 percent of triethanolamine,
0.3% Of active component II;
wherein the phase D comprises the following raw materials:
Three active components of 0.5 percent,
Four active components of 0.5 percent,
0.4 Percent of phenoxyethanol,
0.01 Percent of essence,
Five 0.5% of active component.
5. The cosmetic composition according to claim 1, characterized in that: comprises a phase A, a phase B, a phase C and a phase D;
The phase A comprises the following raw materials in percentage by mass:
4% of mineral oil,
Glycerol stearate 1.5%,
Cetostearyl alcohol 2%,
1.5% Of PEG-20 methyl glucose sesquistearate,
Dioctyl butylene carbonate/vitamin E3%,
Glycerol stearate/PEG-100 stearate 1.5%,
Phenyl trimethicone 1.5%,
0.2 Percent of methylparaben,
0.2 Percent of propyl hydroxybenzoate,
Caprylic/capric triglyceride 3%;
Wherein the phase B comprises the following raw materials:
5% of glycerol,
0.3 Percent of xanthan gum,
0.3% Of carbomer,
2% Of active component,
0.1 Percent of sodium hyaluronate,
5 Percent of butanediol,
The balance being water;
Wherein the phase C comprises the following raw materials:
0.3 percent of triethanolamine,
Active component II 1%;
wherein the phase D comprises the following raw materials:
three active components of 2 percent,
The active component is four percent 2 percent,
0.6 Percent of phenoxyethanol,
0.05 Percent of essence,
Five 2% of active component.
6. An essence emulsion is characterized in that: the cream concentrate comprises the cosmetic composition of any one of claims 1 to 5.
7. A process for preparing the cream concentrate according to claim 6, comprising the steps of:
(1) Adding the phase A raw material into an oil phase pot, stirring and heating to 80-82 ℃ until the phase A raw material is completely dissolved and has no particles for standby;
(2) Adding the B phase raw material into an emulsifying pot, uniformly stirring, heating to 82-85 ℃, homogenizing for 5-10 min until the B phase raw material is completely dissolved and has no particles for later use;
(3) Pumping the materials in the oil phase pot into an emulsifying pot, emulsifying and homogenizing for 3min-5min, and preserving heat for 15min at 82-85 ℃;
(4) Heating the C-phase raw material to 80 ℃, sequentially adding the C-phase raw material into an emulsifying pot, uniformly stirring, homogenizing for 3-5 min, and keeping vacuum cooling;
(5) Cooling to 45deg.C, sequentially adding the D phase materials into emulsifying pot, stirring, filtering, and discharging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211114354.XA CN115836988B (en) | 2022-09-14 | Cosmetic composition, essence emulsion and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211114354.XA CN115836988B (en) | 2022-09-14 | Cosmetic composition, essence emulsion and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115836988A CN115836988A (en) | 2023-03-24 |
| CN115836988B true CN115836988B (en) | 2024-06-07 |
Family
ID=
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19827624A1 (en) * | 1998-06-20 | 1999-12-23 | Beiersdorf Ag | Use of catechols or plant extracts containing them in intensifying natural skin tanning or in stimulating melanogenesis |
| CN110812262A (en) * | 2019-10-24 | 2020-02-21 | 安婕妤化妆品科技股份有限公司 | Anti-wrinkle firming composition |
| CN113456512A (en) * | 2021-07-29 | 2021-10-01 | 广州雅驰化妆品有限公司 | Formula of anti-allergy repairing essence |
| CN114466647A (en) * | 2019-10-04 | 2022-05-10 | 株式会社资生堂 | Solid water-in-oil type emulsion cosmetic |
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19827624A1 (en) * | 1998-06-20 | 1999-12-23 | Beiersdorf Ag | Use of catechols or plant extracts containing them in intensifying natural skin tanning or in stimulating melanogenesis |
| CN114466647A (en) * | 2019-10-04 | 2022-05-10 | 株式会社资生堂 | Solid water-in-oil type emulsion cosmetic |
| CN110812262A (en) * | 2019-10-24 | 2020-02-21 | 安婕妤化妆品科技股份有限公司 | Anti-wrinkle firming composition |
| CN113456512A (en) * | 2021-07-29 | 2021-10-01 | 广州雅驰化妆品有限公司 | Formula of anti-allergy repairing essence |
Non-Patent Citations (2)
| Title |
|---|
| 一种含纳米包裹蜂王浆等活性成分的中老年滋养抗皱霜及其制备方法;杨跃飞;姚刚;;中国蜂业;20121220(第36期);全文 * |
| 皮肤老化相关的关键成分与结构特征概述;周荷益;岑晓娟;王颖;张梦尧;范春晖;于淼;北垣雅人;;香料香精化妆品;20200630(第03期);全文 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101752451B1 (en) | Cosmetic composition having anti-inflammatory activity | |
| CN110974740A (en) | Plant two-step fermentation product with skin irritation and oxidation resisting effects and preparation method and application thereof | |
| CN113648274B (en) | Anti-aging composition and preparation method and application thereof | |
| KR101892097B1 (en) | Cosmetic composition for reducing acne containing extract of senna tora | |
| CN115836988B (en) | Cosmetic composition, essence emulsion and preparation method thereof | |
| JP2006249018A (en) | Antiaging agent | |
| CN114948789A (en) | SOD composition with high-efficiency blue light resisting effect and preparation method thereof | |
| CN115836988A (en) | Cosmetic composition, essence milk and preparation method thereof | |
| KR102310366B1 (en) | Skin external composition for anti-aging comprising cyanidin-3-o-glucoside and natto gum | |
| KR102544792B1 (en) | Composition Comprising Complex Extract of seaweeds Fermented by Lactobacillus Brevis with Anti-Wrinkling and Elasticity, Antioxidant, and Skin Hydration Property as Active Ingredient | |
| KR101780000B1 (en) | Composition for Preventing Skin Wrinkles | |
| KR101416993B1 (en) | Anti-wrinkle cosmetic composition | |
| KR20140145709A (en) | Extract of fermentative Zizyphus jujuba Fructus by Laetiporus sulphureus having lifespan extention of C. elegans via stress response and increasing collegen synthesis, and its cosmetic and therapeutic agent for wrinkle containing the same | |
| CN113827534A (en) | Yandangshan calamus root extracting solution and application thereof in cosmetics | |
| CN109674699B (en) | Composition, preparation method and application thereof | |
| KR20210076419A (en) | Cosmetic composition for preventing hair loss and promoting hair growth containing alfalfa extract, hair cosmetic including the same, and method of manufacturing the same. | |
| CN117281746B (en) | Freckle-removing anti-aging skin care composition and preparation method thereof | |
| KR20210004328A (en) | Cosmetic composition comprising mixed extracts of cnidium officinale and scutellaria baicalensis or compounds seperated from thereof for alleiviating acne and dandruff | |
| CN113398032B (en) | Snow chrysanthemum hydrogel with whitening and freckle removing effects | |
| JP2011184457A (en) | Anti-aging agent | |
| KR20170038449A (en) | Composition containing fisetin for promoting regeneration of skin | |
| KR101441291B1 (en) | Cosmetic composition comprising extract of Baby brier and Lespedeza cuneata for whitening and antioxdiant | |
| KR102622690B1 (en) | Cosmetic composition for protecting skin comprising mixed extracts of acer tegmentosum and magnolia sieboldii as active ingredient | |
| CN115590931A (en) | Activatable NAD + Expressed composition and application thereof in dispelling effects of alcohol and protecting liver | |
| CN118020944A (en) | Composition for promoting generation of I-type and III-type collagen simultaneously, application thereof and food containing composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant |